Beijing Konruns Pharmaceutical Co.,Ltd. (SHA:603590)
China · Delayed Price · Currency is CNY 42.93
+0.38 (0.89%)
Jan 23, 2026, 3:00 PM CST
SHA:603590 Cash Flow Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2015 - 2019 |
|---|---|---|---|---|---|---|---|
Period Ending | Sep '25 Sep 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2015 - 2019 |
Net Income | 57.12 | 42.22 | 150.45 | 101.49 | 147.99 | 183.36 | Upgrade |
Depreciation & Amortization | 33.18 | 33.18 | 42.94 | 38.72 | 36.14 | 30.04 | Upgrade |
Other Amortization | 3.81 | 3.81 | 0.83 | 0.55 | 0.09 | 0 | Upgrade |
Loss (Gain) From Sale of Assets | 0.03 | 0.03 | 0.13 | 0.01 | -0.02 | - | Upgrade |
Asset Writedown & Restructuring Costs | 105.41 | 105.41 | - | 4.06 | 0.01 | 0.08 | Upgrade |
Loss (Gain) From Sale of Investments | -17.66 | -17.66 | 7.22 | 7.65 | -35.64 | -12.69 | Upgrade |
Provision & Write-off of Bad Debts | 4.93 | 4.93 | 5.59 | 1.87 | 1.21 | -0.72 | Upgrade |
Other Operating Activities | -52.8 | -10.08 | 42.93 | 24.82 | 18.53 | 0.41 | Upgrade |
Change in Accounts Receivable | 32.67 | 32.67 | -35.74 | -64.94 | -22.56 | 42.05 | Upgrade |
Change in Inventory | -24.05 | -24.05 | -11.47 | 9.53 | -13.08 | -19.69 | Upgrade |
Change in Accounts Payable | -26.55 | -26.55 | 10.88 | 0.71 | -63.98 | -124.22 | Upgrade |
Change in Income Taxes | - | - | - | - | -14.7 | - | Upgrade |
Change in Other Net Operating Assets | 21.88 | 21.88 | 18.62 | -1.64 | 1.39 | -7.17 | Upgrade |
Operating Cash Flow | 144.43 | 172.25 | 199.35 | 119.69 | 56.22 | 58.41 | Upgrade |
Operating Cash Flow Growth | -12.30% | -13.60% | 66.56% | 112.91% | -3.75% | -77.71% | Upgrade |
Capital Expenditures | -82.21 | -104.02 | -100.91 | -96.31 | -164.65 | -50.37 | Upgrade |
Sale of Property, Plant & Equipment | 0.61 | 0.03 | 0.01 | 0 | 0.05 | - | Upgrade |
Cash Acquisitions | - | - | - | - | -360 | -540 | Upgrade |
Divestitures | - | - | - | - | -0 | - | Upgrade |
Investment in Securities | -34.36 | -114.24 | -364.51 | -251.86 | -113.02 | 158.49 | Upgrade |
Other Investing Activities | 18.77 | 19.83 | 17.7 | 23.66 | 9.87 | 11.05 | Upgrade |
Investing Cash Flow | -97.19 | -198.4 | -447.72 | -324.51 | -627.75 | -420.83 | Upgrade |
Short-Term Debt Issued | - | - | - | - | 3.2 | 24.95 | Upgrade |
Long-Term Debt Issued | - | 217.55 | 147.76 | - | - | - | Upgrade |
Total Debt Issued | 313.34 | 217.55 | 147.76 | - | 3.2 | 24.95 | Upgrade |
Short-Term Debt Repaid | - | - | - | - | -27.42 | - | Upgrade |
Long-Term Debt Repaid | - | -179.41 | -11.56 | -9.94 | -6.46 | - | Upgrade |
Total Debt Repaid | -250.32 | -179.41 | -11.56 | -9.94 | -33.89 | - | Upgrade |
Net Debt Issued (Repaid) | 63.02 | 38.14 | 136.19 | -9.94 | -30.69 | 24.95 | Upgrade |
Issuance of Common Stock | 8.87 | 8.87 | 42.4 | - | - | 62.92 | Upgrade |
Repurchase of Common Stock | -2.6 | -2.6 | -0.03 | - | -124.64 | -74.52 | Upgrade |
Common Dividends Paid | -102.05 | -53.49 | -34.95 | -46.95 | -55.61 | -80 | Upgrade |
Other Financing Activities | -14.09 | 0.82 | - | - | 268.69 | -26.4 | Upgrade |
Financing Cash Flow | -46.85 | -8.27 | 143.62 | -56.89 | 57.76 | -93.04 | Upgrade |
Foreign Exchange Rate Adjustments | -0.29 | -2.82 | -1.37 | -0.75 | -0.15 | -0 | Upgrade |
Net Cash Flow | 0.1 | -37.24 | -106.11 | -262.46 | -513.93 | -455.47 | Upgrade |
Free Cash Flow | 62.22 | 68.22 | 98.44 | 23.38 | -108.43 | 8.03 | Upgrade |
Free Cash Flow Growth | 28.12% | -30.70% | 321.05% | - | - | -96.70% | Upgrade |
Free Cash Flow Margin | 7.14% | 8.27% | 10.70% | 2.70% | -13.39% | 0.99% | Upgrade |
Free Cash Flow Per Share | 0.40 | 0.44 | 0.63 | 0.15 | -0.69 | 0.05 | Upgrade |
Cash Income Tax Paid | 50.46 | 11.53 | 51.86 | 45.63 | 71.81 | 160.62 | Upgrade |
Levered Free Cash Flow | 131.97 | 35.96 | 56.35 | -20.66 | -523.66 | 304.06 | Upgrade |
Unlevered Free Cash Flow | 136.46 | 39.81 | 58.08 | -20.12 | -522.78 | 304.32 | Upgrade |
Change in Working Capital | 10.41 | 10.41 | -50.74 | -59.49 | -112.1 | -142.08 | Upgrade |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.